cyclosporine and Lupus Erythematosus, Cutaneous, Subacute

cyclosporine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (20.00)18.2507
2000's4 (26.67)29.6817
2010's6 (40.00)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Arava, S; Baskaran, N; Gupta, S; Mehta, N1
Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C1
Banovic, F; Linek, M; Olivry, T; Robson, D1
Banovic, F; Linder, KE; Olivry, T; Tobias, JR1
Brown, DC; Casal, ML; Mauldin, EA; Morris, DO1
Bonsmann, G; Kuhn, A; Ruland, V1
Fleck, M; Klein, A; Landthaler, M; Vogt, T; Wenzel, SM1
Abuchar, A; Dehesa, L; Kerdel, FA; Nuno-Gonzalez, A; Vitiello, M1
Christofidou, E; Doulaveri, G; Giannadaki, M; Kontochristopoulos, GJ; Zakopoulou, N1
Heath, M; Raugi, GJ1
Bardagi, M; Fondevila, D; Font, A; Mascort, J1
Grabbe, S; Kolde, G1
Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K1
Bambauer, R; Schiel, R1
de la Mata, J; Fernández-Espartero, MC; Rodríguez, M; Satué, JA1

Reviews

4 review(s) available for cyclosporine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Interventions for cutaneous disease in systemic lupus erythematosus.
    The Cochrane database of systematic reviews, 2021, 03-09, Volume: 3

    Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up

2021
Cutaneous lupus erythematosus: update of therapeutic options part II.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:6

    Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha

2011
The use of cyclosporine in dermatology.
    Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:8

    Topics: Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatomyositis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prurigo; Psoriasis; Pyoderma Gangrenosum; Skin Diseases; Sweet Syndrome; Urticaria

2012
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
    Advances in dermatology, 2004, Volume: 20

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide

2004

Trials

1 trial(s) available for cyclosporine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.
    Veterinary dermatology, 2010, Volume: 21, Issue:4

    Topics: Adalimumab; Animals; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cyclosporine; Dog Diseases; Dogs; Fatty Acids; Female; Genetic Predisposition to Disease; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male

2010

Other Studies

10 other study(ies) available for cyclosporine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus.
    BMJ case reports, 2022, May-27, Volume: 15, Issue:5

    Topics: Chilblains; Cyclosporine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Rituximab

2022
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus.
    Veterinary dermatology, 2017, Volume: 28, Issue:5

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Calcineurin Inhibitors; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Lupus Erythematosus, Cutaneous; Male; Skin; Tacrolimus; Treatment Outcome

2017
Pathology in practice. Psoriasiform lichenoid dermatitis.
    Journal of the American Veterinary Medical Association, 2014, Dec-01, Volume: 245, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prednisolone

2014
Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus.
    The Australasian journal of dermatology, 2011, Volume: 52, Issue:1

    Topics: Adult; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Cutaneous; Methotrexate; Middle Aged; Treatment Outcome

2011
Psoriasis coexisting with subacute cutaneous lupus erythematosus.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2004, Volume: 18, Issue:3

    Topics: Biopsy, Needle; Cyclosporine; Female; Follow-Up Studies; Humans; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Middle Aged; Psoriasis; Risk Assessment; Treatment Outcome

2004
Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie.
    Veterinary dermatology, 2006, Volume: 17, Issue:6

    Topics: Administration, Oral; Animals; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Dog Diseases; Dogs; Lupus Erythematosus, Cutaneous; Male

2006
Coexisting lichen planus and subacute cutaneous lupus erythematosus.
    Clinical and experimental dermatology, 1995, Volume: 20, Issue:3

    Topics: Aged; Aged, 80 and over; Cyclosporine; Female; Humans; Lichen Planus; Lupus Erythematosus, Cutaneous

1995
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
    Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:2 Pt 2

    Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous

1996
Therapeutic plasma exchange and cyclosporine in the treatment of systemic lupus erythematosus.
    Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 1999, Volume: 3, Issue:3

    Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Plasma Exchange; Treatment Outcome

1999
[Blistering cutaneous lesions in a patient with systemic lupus erythematosis].
    Revista clinica espanola, 2001, Volume: 201, Issue:5

    Topics: Adult; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Stevens-Johnson Syndrome

2001